Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(24 sites)
United States
Southern Arizona VA Health Care System, Tucson, AZ, Tucson, Arizona VA Loma Linda Healthcare System, Loma Linda, CA, Loma Linda, California VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, California San Francisco VA Medical Center, San Francisco, CA, San Francisco, California VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois Lexington VA Medical Center, Lexington, KY, Lexington, Kentucky VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis, Minnesota St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis, Missouri New Mexico VA Health Care System, Albuquerque, NM, Albuquerque, New Mexico Syracuse VA Medical Center, Syracuse, NY, Syracuse, New York Asheville VA Medical Center, Asheville, NC, Asheville, North Carolina Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio VA Portland Health Care System, Portland, OR, Portland, Oregon Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia, Pennsylvania Philadelphia MultiService Center, Philadelphia, PA, Philadelphia, Pennsylvania Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville, Tennessee Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas South Texas Health Care System, San Antonio, TX, San Antonio, Texas Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond, Virginia VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington